Zai Lab Limited Stock Analysis & AI Score
Zai Lab Limited (ZLAB) has an ST Score of 49.5 (C+), driven by its Forecast (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $53.75 price target (+112.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Zai Lab Limited (ZLAB) has an ST Score of 49.5 (C+), driven by its Forecast (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $53.75 price target (+112.6% upside).
- Strongest
- ForecastA
- Weakest
- Financial StrengthD-
All factor grades
- ForecastA
- ProfitabilityB+
- MomentumB+
- ValuationB-
- GrowthC-
- Financial StrengthD-
- Piotroski2/9
Contact
ZLAB stock: frequently asked questions
What is ZLAB's ST Score?
Zai Lab Limited (ZLAB) has an ST Score of 49.5 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ZLAB a buy, hold, or sell?
Analysts rate ZLAB a Buy, with a price target of $53.75 (+112.6% vs the current price). Our ST Score grades it C+ (49.5/100). The ST Score is a data-driven signal, not a recommendation.
What are ZLAB's factor grades?
Valuation B-, Profitability B+, Financial Strength D-, Momentum B+, Growth C-, Forecast A.
What is ZLAB's valuation grade?
Zai Lab Limited (ZLAB) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ZLAB's growth grade?
Zai Lab Limited (ZLAB) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ZLAB's profitability grade?
Zai Lab Limited (ZLAB) earns a profitability grade of B+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ZLAB's financial strength grade?
Zai Lab Limited (ZLAB) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ZLAB?
The average analyst price target for Zai Lab Limited (ZLAB) is $53.75 from 11 analysts, which is +112.6% versus the recent price of $25.28.
What is ZLAB's Piotroski score?
Zai Lab Limited (ZLAB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.